Judith M Matthews's Insider Trades & SAST Disclosures
Judith M Matthews's most recent trade in Iterum Therapeutics Plc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Judith M Matthews.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 6,666 | 0 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2023 | 6,666 | 11,018 (0%) | 0% | 0 | Ordinary Shares | |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.96 per share. | 11 Mar 2023 | 2,883 | 8,135 (0%) | 0% | 1.0 | 2,768 | Ordinary Shares |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.31 per share. | 11 Mar 2022 | 63,340 | 65,292 (0%) | 0% | 0.3 | 19,635 | Ordinary Shares |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 1,936,000 | 1,936,000 | - | - | Stock Option (Right to Buy) | |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 200,000 | 200,000 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 62,500 | 62,500 (0%) | 0% | 0 | Ordinary Shares | |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.73 per share. | 25 Jan 2021 | 33,868 | 28,632 (0%) | 0% | 1.7 | 58,592 | Ordinary Shares |
| Iterum Therapeutics Plc | Judith M. Matthews | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.64 per share. | 30 Sep 2020 | 56,130 | 0 (0%) | 0% | 1.6 | 92,053 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges